We are live on
!
Find out more
JSMC
Jess S. Morgan & Co Portfolio holdings
AUM
$115M
1-Year Est. Return
16.65%
This Fund
S&P 500
This Quarter
Est. Return
+0.44%
1 Year Est. Return
-16.65%
3 Year Est. Return
+69.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$18.5M
(+19%)
Cap. Flow
+$16.4M
Cap. Flow
% of AUM
14.24%
Top 10 Holdings %
Top 10 Hldgs %
47.01%
Holding
39
New
2
Increased
27
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraPro Short S&P 500
SPXU
|
+$9.24M |
| 2 |
ProShares UltraPro Short QQQ
SQQQ
|
+$3.88M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$3.09M |
| 4 |
Broadcom
AVGO
|
+$1.06M |
| 5 |
CKPT
Checkpoint Therapeutics
CKPT
|
+$902K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$2.95M |
| 2 |
Axsome Therapeutics
AXSM
|
+$1.3M |
| 3 |
Intel
INTC
|
+$224K |
| 4 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$104K |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$97.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.17% |
| 2 | Technology | 11.66% |
| 3 | Consumer Staples | 4.02% |
| 4 | Industrials | 2.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Russell 3000 ETF
IWV
$19.6B
| $2M | 1.74% |
9,679
-101
| -1% | -$23.2K |
|
|
CKPT
27
DELISTED
Checkpoint Therapeutics
CKPT
| $1.97M | 1.71% |
189,469
+75,737
| +67% | +$902K |
|
28
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $1.83M | 1.59% |
30,804
+108
| +0.4% | +$7.37K |
|
29
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $1.42M | 1.24% |
11,761
+1,102
| +10% | +$142K |
|
30
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.48B
| $1.1M | 0.95% |
53,432
+1,565
| +3% | +$36.3K |
|
31
Vanguard Total Stock Market ETF
VTI
$658B
| $1.05M | 0.91% |
5,845
+1,850
| +46% | +$369K |
|
32
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
| $933K | 0.81% |
18,655
+920
| +5% | +$52.3K |
|
33
Microsoft
MSFT
$2.98T
| $748K | 0.65% |
3,212
+150
| +5% | +$39.6K |
|
34
NVIDIA
NVDA
$5.02T
| $744K | 0.65% |
61,320
| – | – |
|
35
Clene
CLNN
$72.7M
| $314K | 0.27% |
5,600
+1,237
| +28% | +$82K |
|
36
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$617M
| $200K | 0.17% |
1,425
-58
| -4% | -$10.6K |
|
|
37
Adobe
ADBE
$93.5B
| – | – |
-8,047
| Closed | -$2.95M |
|
|
38
Intel
INTC
$487B
| – | – |
-6,000
| Closed | -$224K |
|
39
Lineage Cell Therapeutics
LCTX
$292M
| – | – |
-20,000
| Closed | -$32K |
|
Similar funds
RCM
DIV
WC
FFC
SA
MCA
SCM
LAM
Jess S. Morgan & Co's Q3 2022 Portfolio in Review
As of Q3 2022, Jess S. Morgan & Co held 39 positions worth $115M, up 19% from $96.4M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jess S. Morgan & Co deployed $16.4M of net new capital in Q3 2022, opening 2 new positions and adding to 27 existing holdings. Its largest new stake was ProShares UltraPro Short S&P 500: 26,964 shares worth $12.1M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Axsome Therapeutics, an estimated $1.3M trimmed.
- Jess S. Morgan & Co's largest Q3 2022 buy was ProShares UltraPro Short S&P 500: 26,964 shares worth $12.1M.
- Jess S. Morgan & Co added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2022, an estimated $3.09M increase.
- Jess S. Morgan & Co's biggest Q3 2022 reduction was Axsome Therapeutics, cutting an estimated $1.3M.
- Jess S. Morgan & Co fully exited Adobe in Q3 2022, selling an estimated $2.95M.
- Jess S. Morgan & Co's ten largest holdings make up 47% of its $115M portfolio in Q3 2022.
- Jess S. Morgan & Co opened 2 new positions and closed 3 in Q3 2022.
- Jess S. Morgan & Co's portfolio value rose 19% quarter-over-quarter to $115M.
Based on Jess S. Morgan & Co's 13F filing for Q3 2022, filed 21 Oct 2022.